|
ORIGINAL ARTICLE |
|
Year : 2014 | Volume
: 4
| Issue : 4 | Page : 68-71 |
|
Primary oral non-Hodgkin's lymphoma - A clinicopathologic study with immunohistochemical analysis |
|
Dominic Augustine1, Bala Sekar2, R Thiruneervannan3, Murali Sundhar2, Donga Reddy2, Shankar Gouda Patil4
1 Department of Oral and Maxillofacial Pathology, Bangalore Institute of Dental Sciences and Hospital, Lakkasandra, Bangalore, India 2 Department of Oral and Maxillofacial Pathology, Vinayaka Missions Sankarachariyar Dental College and Hospital, Ariyanoor, Salem, Tamil Nadu, India 3 Department of Oral Medicine and Radiology, Vinayaka Missions Sankarachariyar Dental College and Hospital, Ariyanoor, Salem, Tamil Nadu, India 4 Department of Oral and Maxillofacial Pathology, M. S. Ramaiah Dental College and Hospital, M. S. Ramaiah Educational Campus MSRIT Post, MSR Nagar, Bangalore, India
Date of Web Publication | 13-Nov-2014 |
Correspondence Address: Dominic Augustine Assistant Professor, Department of Oral and Maxillofacial Pathology, Bangalore Institute of Dental Sciences and Post Graduate Research Centre, Hosur Main Road, Lakkasandra, Bangalore 560 029, Karnataka India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2231-0762.144603
|
|
Abstract | | |
Context: Non-Hodgkin's lymphoma (NHL) is a group of highly diverse malignancies whose prognosis depends on the histologic type and associated factors like HIV positivity. Aims: The aim of this study was to evaluate eight cases of NHL for their histologic type and HIV positivity, since both are major prognostic factors for NHL. Settings and Design: Eight cases of primary NHL of the oral cavity were evaluated for age, sex, clinical presentation, and the histologic type, along with immunohistochemistry. These cases were also evaluated for HIV positivity. Materials and Methods: NHL cases which were diagnosed through the dental OPD and subsequent biopsy procedure were chosen. The patient data, including age, sex, location, clinical presentation, radiographic presentation, metastasis, and histologic subtype, according to the World Health Organization (WHO) classification were tabulated. Immunohistochemical markers were used to confirm the cell type. CD20 and CD3 were used for B cell and T cell, respectively. Subsequent western blot analysis was carried out for HIV detection. Results: 75% of the NHL was of B-cell type; of this, 83% was found to be diffuse large B-cell lymphoma, which is an aggressive variant. 62.5% of cases were found to be HIV positive. Conclusions: This study emphasizes the need for HIV investigation in NHL cases and the need to determine the histologic type, both of which significantly affect the treatment outcome and prognosis.
Keywords: HIV, non-Hodgkin′s lymphoma, oral cavity
How to cite this article: Augustine D, Sekar B, Thiruneervannan R, Sundhar M, Reddy D, Patil SG. Primary oral non-Hodgkin's lymphoma - A clinicopathologic study with immunohistochemical analysis. J Int Soc Prevent Communit Dent 2014;4, Suppl S1:68-71 |
How to cite this URL: Augustine D, Sekar B, Thiruneervannan R, Sundhar M, Reddy D, Patil SG. Primary oral non-Hodgkin's lymphoma - A clinicopathologic study with immunohistochemical analysis. J Int Soc Prevent Communit Dent [serial online] 2014 [cited 2022 May 25];4, Suppl S1:68-71. Available from: https://www.jispcd.org/text.asp?2014/4/4/68/144603 |
Introduction | |  |
Non-Hodgkin's lymphoma (NHL) is a group of diverse malignancies and has a tendency to also affect the tissues that usually do not contain lymphoid cells. From 20 to 30% of NHL arises from extranodal sites. [1] The hard palate and gingiva are commonly involved. Other sites such as tongue, buccal mucosa, lips, and floor of the mouth have been reported quite infrequently. [2]
T-cell NHL is aggressive and patients have poorer prognosis compared to the B-cell type. Hence, this differentiation is needed. [3]
The aim of this study is to emphasize the need for HIV investigation in NHL cases and the need to determine the histologic type, both of which significantly affect the treatment outcome and prognosis.
Materials and methods | |  |
NHL cases which were diagnosed through the dental OPD and subsequent biopsy procedure were chosen. The patients complained of a swelling or ulcerated growth. The patient data, including age, sex, location, clinical presentation, radiographic presentation, metastasis, and histologic subtype, according to the World Health Organization (WHO) classification were tabulated. CD20 and CD3 were used to differentiate B-cell lymphomas and T-cell lymphomas.
Paraffin-embedded tissue blocks were cut to produce 4 μm thick sections and stained by the Novolink™ Max Polymer detection system (Novocastra TM, London, UK). After the sections were re-hydrated through a graded series of alcohol, epitope retrieval was performed. Endogenous peroxidase was blocked by using a peroxidase block of the kit. Protein block was used to prevent non-specific binding. The sections were subsequently incubated with optimally diluted primary antibodies. The primary antibodies used were: Mouse antihuman CD3 and mouse antihuman CD20. The polymer recognizes the primary antibody.
The sections were then incubated with the substrate/chromogen 3',3'-diaminobenzidine (DAB). Sections were then counterstained with hematoxylin and coverslipped.
The slides were observed under a microscope and the results interpreted. The cases were also tested for HIV positivity by enzyme-linked immunosorbent assay (ELISA) and western blot analysis.
Results | |  |
The following results were obtained. Patients were in the 3 rd to 6 th decade of life, with one case being of age 15 years. Majority were of B-cell type [75% (6 cases)]; among these, 83% (5 cases) were found to be diffuse large B-cell lymphoma (DLBCL), which is an aggressive variant. 62.5% (5 cases) were males and the mean age was 42 years.
Maxilla was involved in six cases and mandible in two cases which were also intraosseous, and the greatest size reported was 8 × 4 cm [Figure 1]a-1c.
The lesions appeared as swellings and were ulcerated in a few cases; their color varied from pinkish to erythematous [Figure 2]a and 2b. | Figure 1: (a) Extraoral view of the mandibular swelling. (b) Large destructive lesion involving the both cortical plates. (c) orthopantomogram (OPG) showing pathologic fracture
Click here to view |
 | Figure 2: (a) Ulcerative growth involving the right retromolar region. (b) Erythematous lesion of the maxillary gingiva
Click here to view |
Metastasis to regional nodes was present in one case which involved the posterior palate. 62.5% (5 cases) of the cases were found to be seropositive for HIV on performing ELISA and subsequent western blot [Table 1]. Among the five HIV-positive patients, one had developed a recurrence of NHL and another had died during the course of treatment.
The microscopic pattern was predominantly that of round malignant cells fitting into the diagnosis of NHL. Nuclear pleomorphism, hyperchromatism, altered nuclear-cytoplasmic ratio, mitosis, and vascular invasion were present in most of the cases [Table 2].
Immunohistochemistry was done using anti-CD3 for T-cell lineage and anti-CD20 for B-cell lineage; six cases were positive for CD20 and two cases for CD3. Among the six B-cell lymphomas, five were diffuse large cell and one was follicular B-cell lymphoma [Figure 3]a and 3b. Both the T-cell lymphomas were anaplastic large T-cell lymphomas [Figure 4]a and 4b. | Figure 3: (a) Histologic section showing the malignant lymphocytes in a B-cell lymphoma (H and E stain at 10 × magnification). (b) Immunohistochemistry showing positivity for CD20 marker (IHC stain at 10 × magnification)
Click here to view |
 | Figure 4: (a) Histologic section showing large malignant lymphocytes in a T-cell lymphoma (H and E stain at 40 × magnification). (b) Immunohistochemistry showing positivity for CD3 marker (IHC stain at 40 × magnification)
Click here to view |
Discussion | |  |
Twenty-five to forty percent of HIV-positive patients would develop a malignancy, with approximately 10% developing NHL. NHL is a heterogeneous malignancy characterized by abnormal proliferation of lymphoid cells and/or their precursors. [4]
The risk factors include exposure to pesticides and radiation, long-term immunosuppression, and autoimmune diseases including rheumatoid arthritis, systemic lupus erythematous, and Sjφgren syndrome. Certain infections, including Epstein-Barr virus (EBV), human T-cell lymphotropic virus 1 (HTLV-1), HIV, Helicobacter pylori, Chlamydia, and human herpesvirus-8 (HHV-8, KSHV), are known to be associated with a risk for development of NHL and, in particular, mucosa-associated lymphoid tissue (MALT) lymphomas. [5]
Oral lesions may appear as an erythematous, painless enlargement, often with surface ulceration secondary to trauma. In patients with removable oral prosthetics, the tissue enlargement may interfere with proper seating and function. NHL rarely presents with deep oral ulceration. [6]
Patients with HIV infection are at higher risk of developing NHL and the aggressive B-cell lymphoma is one of the most commonly seen variants in these individuals. [7]
The age of AIDS-related lymphoma patients seems to vary. Five of our eight cases turned out to be HIV positive. The age group affected by NHL related to AIDS is considerably younger than that of unrelated NHL. [7]
DLBCL is considered an aggressive, yet treatable neoplasm with a variable clinical course. An initial remission of 60-80% has been reported with chemotherapy. [8]
The cells of DLBCL are roughly 3 times the diameter of small lymphocytes and have a vesicular appearing nucleus, usually with prominent membrane-bound chromatin. Nucleoli are usually prominent. [9] These findings were similar to cases. In the present study, out of the six B-cell lymphomas, five were DLBCL and one was a follicular lymphoma.
Angioimmunoblastic T-cell lymphoma is a common T-cell lymphoma which accounts for 15-20% of the reported cases and 4-6% of the lymphomas. It is an aggressive lesion showing rapid growth, destruction of the adjacent tissue, and is associated with poor prognosis. Average age at presentation is about 64 years, with a slight male predilection. [10] These findings are similar to those observed in the present study. Among the eight NHL cases, two were T-cell lymphomas.
High-dose chemotherapy followed by stem cell transplantation has only been evaluated in a few patients. Treatment with anthracycline-based combination results in satisfactory remission rates of 50-70%. Only 10-30% of subjects have shown good survival rates. [11] This emphasizes the need to differentiate B-cell lymphomas from T-cell lymphomas which have a different regimen.
In our cases, the B-cell lymphomas were given four cycles of CHOP (Cyclophosphamide, Hydroxydaunorubicin, Oncovin, and Prednisone) chemotherapy. The T-cell lymphomas which require aggressive therapy were treated by additional anthracycline. Our patients have remained disease-free for 5 years now. Among the HIV-positive cases, one died due to the disease and another patient has had a relapse after four cycles of chemotherapy.
Conclusion | |  |
This study clearly shows the poorer prognosis of NHL associated with HIV. A proper histopathologic analysis along with immunohistochemical evaluation aids in the accurate diagnosis that helps in ideal management. This article emphasizes the need for HIV investigation in NHL cases and the need to determine the histologic type, both of which significantly affect the treatment outcome and prognosis.
Acknowledgment | |  |
The authors wish to thank the Department of Oral medicine and Oral Surgery, Vinayaka Missions Sankarachariyar Dental College and Hospital, Tamil Nadu, India.
References | |  |
1. | Clearly KR, Batsakis JG. Sinonasal lymphomas. Ann Otol Rhinol Laryngol 1994;103:911-4. |
2. | Wolvius EB, van der Valk P, van der Wal JE, van Diest PJ, Huijgens PC, van der Waal I, et al. Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol 1994;30B:121-5. |
3. | Chen CC, Raikow RB, Sonmez-Alpan E, Swerdlow SH. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Mol Morphol 2000;8:1-11. |
4. | Lu P. Staging and classification of lymphoma. Semin Nucl Med 2005;35:160-4. |
5. | Young GA, Iland HJ. Clinical perspectives in lymphoma. Intern Med J 2007;37:478-84. |
6. | Raut A, Huryn J, Pollack A, Zlotolow I. Unusual gingival presentation of post-transplantation lymphoproliferative disorder: A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:436-41. |
7. | Gabarre J, Lepage E, Thyss A, Tubiana R, Bastion Y, Schlaifer D, et al. Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma. Ann Oncol 1995;6:1025-32. |
8. | Møller MB, Christensen BE, Pedersen NT. Prognosis of localized diffuse large B-cell lymphoma in younger patients. Cancer 2003;98:516-21. |
9. | Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92. |
10. | Rüdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non- Hodgkin's Lymphoma Classification Project. Ann Oncol 2002;13:140-9. |
11. | Reiser M, Josting A, Soltani M, Staib P, Salzberger B, Diehl V, et al. T-cell non-Hodgkin's lymphoma in adults: Clinicopathological characteristics, response to treatment and prognostic factors. Leuk Lymphoma 2002;43:805-11. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2] |
|
This article has been cited by | 1 |
Primary extranodal Non-Hodgkin’s Lymphoma of the mandibular condyle: A case report and literature review |
|
| Lijuan Ma,Zhankui Xing,Zhankui khaled Alkebsi,Lan Yang,Tingying Xiao,Zhiqiang Wang,Essam Ahmed Al-Moraissi | | Oral and Maxillofacial Surgery Cases. 2019; : 100130 | | [Pubmed] | [DOI] | | 2 |
Pathological Mandibular Fracture Associated With Diffuse Large B-Cell Lymphoma in HIV-Positive Patient |
|
| Marina Reis Oliveira,Darcy Fernandes,Marisa Aparecida Cabrini Gabrielli,Cleverton Roberto de Andrade,Cláudia Maria Navarro,Valfrido Antonio Pereira-Filho | | Journal of Craniofacial Surgery. 2016; 27(8): 2084 | | [Pubmed] | [DOI] | | 3 |
Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series |
|
| Pauli Vähämurto,Kaija Silventoinen,Seija I. Vento,Marja-Liisa Karjalainen-Lindsberg,Aaro Haapaniemi,Leif Bäck,Susanna Mannisto,Sirpa Leppä,Antti A. Mäkitie | | European Archives of Oto-Rhino-Laryngology. 2016; | | [Pubmed] | [DOI] | | 4 |
Primary non-Hodgkin’s lymphoma of the gingiva: a case report and review of the literature |
|
| Ilson Sepúlveda,Max Schorwer,Enrique Platin,Milly Yañez,Felipe Fredes | | memo - Magazine of European Medical Oncology. 2016; 9(4): 183 | | [Pubmed] | [DOI] | | 5 |
Intraosseous Non-Hodgkin Lymphoma Mimicking a Periapical Lesion |
|
| Débora Lima Pereira,Diego Tetzner Fernandes,Alan Roger Santos-Silva,Pablo Agustin Vargas,Oslei Paes de Almeida,Márcio Ajudarte Lopes | | Journal of Endodontics. 2015; 41(10): 1738 | | [Pubmed] | [DOI] | |
|
|
 |
|
|
|
|
|
|
|
Article Access Statistics | | Viewed | 2531 | | Printed | 65 | | Emailed | 0 | | PDF Downloaded | 278 | | Comments | [Add] | | Cited by others | 5 | |
|

|